Lulu Eva Rakhmilla

Lulu Eva Rakhmilla

Auto-generated profile, based on publicly available information

Lulu Eva Rakhmilla

Department of Public Health, Epidemiology and Biostatistic Division, Faculty of Medicine, Universitas Padjadjaran, Bandung 45363, Indonesia

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
SSSusi Susanah
Susi Susanah
LRLulu Eva Rakhmilla
Lulu Eva Rakhmilla
MGMohammad Ghozali
Mohammad Ghozali
JTJessica Oktavianus Trisaputra
Jessica Oktavianus Trisaputra
OMOctawyana Moestopo
Octawyana Moestopo
AMAni Melani Maskoen
Ani Melani Maskoen
Background. Iron overload in severe β‐thalassemia is a serious complication that occurs during the course of the disease. Information about the iron status during initial illness with β‐thalassemia major seemed to be limited. This study is aimed at analyzing iron status, serum hepcidin, and growth differentiation factor 15 (GDF15) levels in newly diagnosed β‐thalassemia major. Methods. A case‐control study was performed at Dr. Hasan Sadikin General Hospital, which included 41 children with newly diagnosed β‐thalassemia major. Age‐ and sex‐matched controls were enrolled. The subjects had no blood transfusion, had normal liver function, and had no sign of inflammation. The groups were compared in terms of the levels of hemoglobin (Hb), serum ferritin (SF), transferrin saturation (TS), serum hepcidin, and GDF15 as iron homeostasis parameters. Results. Of the 41 newly diagnosed β‐thalassemia major patients, those who were less than 24 months old had significantly lower median Hb levels than controls (5.0 vs. 11.7 g/dL, P < 0.001). The median SF and TS levels were significantly higher than those in controls (315.0 vs. 29.0 ng/mL, P < 0.001; 70.6 vs. 16.5%, P < 0.001), and median hepcidin was at the normal limit, but the value was higher in patients (251.0 vs. 123.1 ng/mL, P < 0.001). The median GDF15 level was significantly higher in patients (2,095.3 vs. 342.4 pg/mL, P < 0.001). There was a positive correlation between SF‐TS, SF‐hepcidin, TS‐hepcidin, SF‐GDF15, TS‐GDF15, and hepcidin‐GDF15 (P < 0.001). Conclusion. In newly diagnosed β‐thalassemia major, an increase in iron status occurred. This may be caused by increased iron absorption due to massive erythropoietic activity, characterized by an increase in GDF15 levels, which does not cause hepcidin suppression. The iron homeostasis response seems to be physiologically indicated by a tendency to increase hepcidin levels.

1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
SSSusi Susanah
Susi Susanah
PIPonpon S. Idjradinata
Ponpon S. Idjradinata
NSNur M. Sari
Nur M. Sari
LRLulu E. Rakhmilla
Lulu E. Rakhmilla
YSYunia Sribudiani
Yunia Sribudiani
OMOctawyana Moestopo
Octawyana Moestopo
Background. Iron overload is still a major complication of severe β‐thalassemia. Indication to start iron chelation therapy is based on serum ferritin (SF) or transferrin saturation (TS) level or the amount of transfusion. The goal of this study is to analyse the pattern of iron status, the amount of transfusion regarding the time to start iron chelator, and serum hepcidin levels in newly diagnosed severe β‐thalassemia. Methods. A prospective cohort study was performed at Hasan Sadikin General Hospital on newly diagnosed severe β‐thalassemia patients. Subjects had not received any blood transfusion with normal liver function test, CRP, and IL‐6 levels who consumed normal diet according to age. The SF and TS levels indicate iron status, while hepcidin level indicates iron regulator status. Main indicator to start iron chelation therapy when SF level ≥1.000 ng/mL, TS level ≥70%, or after receiving transfusion at least 10 times. Statistical analysis used Mann–Whitney and Spearman. Results. Forty‐two newly severe β‐thalassemia, 30 (71.4%), were diagnosed before 1 year old, mean 9.9 ± 6.4 months, range 2–24 months. Range amount of transfusion until SF level reached ≥1,000 ng/mL were 4‐12 times, mean 7 ± 2 times. Mean SF and TS level at diagnosis were 365.6 ± 194.9 ng/mL and 67.3 ± 22.5%, while hepcidin level was normal, mean 242.6 ± 58 ng/mL. 36/42 patients have reached SF >1000 ng/mL with amount of transfusion less than 10 times. There was no significant difference of SF, TS, and hepcidin levels when SF >1000 ng/mL in the group with amount of transfusion 7–12 and less than 7 (p = 0.454, p = 0.084, p = 0.765), respectively. A significant positive correlation between SF and amount of transfusion was observed (p < 0.001; r = 0.781). Conclusion. Iron overload in severe β‐thalassemia patients might occur earlier even before they received 10 times transfusion. Hepcidin serum level tends to increase when iron overload just started.

1 July 2021 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
NSNur Melani Sari
Nur Melani Sari
LRLulu Rakhmilla
Lulu Rakhmilla
MBMuhammad Hasan Bashari
Muhammad Hasan Bashari
ZZZulfan Zazuli
Zulfan Zazuli
NSNur Suryawan
Nur Suryawan
PIPonpon Idjradinata
Ponpon Idjradinata
The administration of high-dose methotrexate (HD-MTX) requires an accurate monitoring of blood MTX levels to determine the regimen of leucovorin rescue and urine alkalinization to prevent toxicity. However, it is technically and logistically challenging to screen patients routinely in limited-resource settings. This study aimed to evaluate blood MTX levels at 24- and 48-hours from start of infusion in relation to clinical toxicity in childhood ALL. Methods: A prospective cohort study was conducted on 32 consecutive children with acute lymphoblastic leukemia (ALL) who had received at least one cycle of 1 g/m2 HD-MTX intravenous infusion as a part of consolidation treatment based on the 2013 Indonesian ALL Protocol. In total, 68 cycles were evaluated. Serum MTX concentrations were measured using enzyme immunoassay. MTX toxicity was categorized using common toxicity criteria (CTCAE) 3.0 version. The association between MTX level and clinical toxicity was assessed by non-parametric analysis. Results: The 24-hours MTX level was median 29.8 ng/mL (0.065 µmol/L) (IQR 8.1–390.6) with a modest decrease in 48-hours MTX serum level in all cycles (median 28.3 ng/mL and 0.062 µmol/L; IQR 0.35–28.7; p <0.05). The two most common toxicities were hepatotoxicity (32.2%) and neutropenia (30.9%). Nephrotoxicity and febrile neutropenia occurred in 8.8% and 5.8% of patients, respectively, with low percentage of mucositis (4.3%) and thrombocytopenia (5.6%) recorded. No statistically significant association was found between MTX levels and clinical toxicity, except for liver toxicity.Conclusion: Serum MTX levels at 24-hours and 48-hours are low, followed by only 4.4% grade III/IV hepatotoxicity and 26,4% grade III/IV neutropenia. There is no significant association between the clinical toxicity and MTX levels at the two points of measurement. An attempt to increase the MTX dose and/or to introduce a loading dose should be considered in subsequent ALL protocol as supported by further pharmacokinetic MTX studies in the Indonesian population.

1 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
SSSusi Susanah
Susi Susanah
HRHarry Raspati
Harry Raspati
NSNur Melani Sari
Nur Melani Sari
LRLulu Eva Rakhmilla
Lulu Eva Rakhmilla
YSYunia Sribudiani
Yunia Sribudiani
AMAni Melani Maskoen
Ani Melani Maskoen
Background. The development of factor VIII (FVIII) inhibitor in patients with hemophilia A (PWHA) is a great challenge for hemophilia care. Both genetic and environmental factors led to complications in PWHA. The development of inhibitory antibodies is usually induced by the immune response. Tumor necrosis factor α (TNF‐α), one of the cytokines, might contribute to its polymorphism. In this study, we investigated the clinical factors, level of serum TNF‐α, and polymorphism of c.−308G > A TNF − α gene in inhibitor development in severe PWHA. Methods. A cross‐sectional study was conducted among all PWHA in West Java province. The clinical parameters, FVIII, FVIII inhibitor, and serum TNF‐α level were assessed. The genotyping of −380G > A TNF‐α gene polymorphism was performed using polymerase chain reaction and Sanger sequencing. Results. Among the 258 PWHA, 216 (83.7%) were identified as severe PWHA. The FVIII inhibitor was identified in 90/216 (41.6%) of severe PWHA, consisting of 45 high‐titer inhibitors (HTI) and 45 low‐titer inhibitors (LTI). There was a significant correlation between serum TNF‐α level and the development of HTI (p = 0.043). The cutoff point of serum TNF‐α level, which can be used to differentiate between HTI and LTI, was 11.45 pg/mL. The frequency of FVIII replacement therapy was significant only in HTI of severe PWHA regarding serum TNF‐α level (p = 0.028). There is no correlation between polymorphisms of −380G > A TNF‐α gene and inhibitor development (p = 0.645). Conclusions. The prevalence of FVIII inhibitor in severe PWHA in West Java, Indonesia, was 41.6%. The frequency of replacement therapy is a risk factor for inhibitor development. Serum TNF‐α level might be used to differentiate between high and low inhibitor levels in severe hemophilia A, and this might support decision making regarding treatment options for inhibitor in severe hemophilia A.

2 April 2020
Verified
Journal Article
Open access
BRB.P. Ramadhani
B.P. Ramadhani
ASA.Y. Soeroto
A.Y. Soeroto
HSH. Suryadinata
H. Suryadinata
LRL.E. Rakhmilla
L.E. Rakhmilla
High epidemiology of influenza in the world and Indonesia causes some groups to have high risk for getting infected with influenza, one of which is healthcare workers. The low rates of influenza vaccination among healthcare workers, especially in nurses, raise the need for an educational strategy to prevent influenza. This study aimed to measure the level of knowledge, attitude and practice among nurses in suburban hospital in West Java. This was a cross-sectional study with a random sampling method which started on July-August 2018 at Annisa Medical Center General Hospital. Knowledge, attitude, and practice of research subjects were measured using questionnaire containing 37 items. The questionnaire was the result of adaptation of several questionnaires and a validity test has been was conducted. The data obtained was then analyzed descriptively by the proportion of the score of knowledge, attitude, and practice. Of 104 respondents, 19% respondents had a low level, 74% respondents had a moderate level and 7% had a high level of knowledge toward influenza vaccination. For attitude, 67% of the respondents had a positive attitude and 33% respondents had a negative attitude. The study also showed that 58% of the respondents had a positive practice and 42% respondents had negative attitude. Nurses possess adequate knowledge and showed a positive attitude and practice toward influenza vaccination. A continous educational strategy was needed to improve nurses’ knowledge, attitude and practice about influenza vaccination.

15 May 2025 in Children
Verified
Journal Article
Open access
PDF file
SSSusi Susanah
Susi Susanah
DMDavid Marcelius
David Marcelius
LRLulu Eva Rakhmilla
Lulu Eva Rakhmilla
RRRini Rossanti
Rini Rossanti
SFSindy Amalia Febrianti
Sindy Amalia Febrianti
BSBudi Setiabudiawan
Budi Setiabudiawan
Background/Objectives: Anemia, particularly iron-deficiency anemia (IDA), and stunting remain notable early childhood public health challenges in Indonesia; however, studies are still scarce. This study aimed to determine the co-occurrence of anemia and stunting (CAS), their prevalence, and the associated factors, as well as to describe the erythrocyte parameters. Methods: Approximately 2200 children aged 6–24 months were identified by midwives to have problematic nutritional status at Bandung Regency, West Java, Indonesia. These children were included in the population frame for a cohort study of vitamin D deficiency, vitamin D binding protein, and its impact on neurodevelopmental functions. A cross-sectional study was nested in the cohort study. The subjects were selected by stratified random sampling of 270 villages to meet the required number of samples. Medical doctors reassessed the anthropometric measurements and performed guided interviews to collect associated factors for IDA and CAS. Erythrocyte profiles of the children were examined from venous blood. Results: One hundred and ninety-four subjects were included in the analysis, among which 54.1% were stunted. Anemia was present in 40.7% of the subjects, largely due to IDA (87.3%). A wasting child and the factor of low paternal education (up to elementary school) were associated with IDA (aOR of 7.12 and aOR of 3.32, p < 0.05, respectively). Co-occurrence of anemia and stunting was found in 41/194 (21.1%) subjects, but it did not show significant association. Conclusions: Anemia and stunting were prevalent among children aged 6–24 months, but no associations were found between anemia and stunting in this study. Iron deficiency was the main cause of anemia, and it was associated with wasting and low paternal education.